|
Causes of deviation from guidelines from patient’s view
|
|---|
|
n
|
69
|
8
|
15
|
8
|
4
|
15
|
53
|
12
|
21
|
|---|
|
Reason (in %)
|
Anti-HT
|
Metformin
|
HF: βB
|
HF: RAAS-I
|
HF: AldoA
|
AF: OAK
|
CVD: statin
|
CVD: antipltlt
|
MCI: βB
|
|
I don’t know
|
91.3
|
50.0
|
60.0
|
62.5
|
75.0
|
66.7
|
30.2
|
50.0
|
76.2
|
|
I don’t need it
|
2.9
|
25.0
|
26.7
|
37.5
|
25.0
| |
45.3
|
25.0
|
9.5
|
|
I don’t want it
| |
12.5
| | | |
13.3
|
7.5
| | |
|
Adverse drug event
|
4.3
| |
13.3
| | |
6.7
|
7.5
| |
4.8
|
|
Falsely discontinued
|
1.4
|
12.5
| | | |
13.3
|
9.4
|
25.0
|
9.5
|
|
Causes of deviation from guidelines from physician’s view
|
|
n
|
69
|
8
|
15
|
8
|
4
|
15
|
53
|
12
|
21
|
|
Reason (in %)
|
Anti-HT
|
Metformin
|
HF: βB
|
HF: RAAS-I
|
HF: AldoA
|
AF: OAK
|
CVD: statin
|
CVD: PAI
|
MCI: βB
|
|
Falsely not indicated GP
|
78.3
|
37.5
|
80.0
|
62.5
|
50.0
|
33.3
|
56.6
|
33.3
|
52.4
|
|
Falsely not indicated s/h
|
8.7
|
12.5
|
6.7
|
25.0
|
25.0
|
6.7
|
7.5
|
8.3
|
23.8
|
|
Noncompliance
|
2.9
|
25.0
| | | |
20.0
|
17.0
|
25.0
|
9.5
|
|
Adverse drug event
|
8.7
|
25.0
|
6.7
|
12.5
|
25.0
|
6.7
|
11.3
|
25.0
|
4.8
|
|
Falsely discontinued
|
1.4
| |
6.7
| | |
6.7
|
3.8
| | |
|
Contraindication
| | | | | |
26.7
| |
8.3
|
9.5
|
|
Avoidance of polypharmacy
| | | | | | |
3.8
| | |
- Summation does not add up to 100% due to rounding error.
- Anti-HT: antihypertensive medication (RAAS-inhibitor or thiazide or calcium channel blocker or β-blocker).
- Metformin: metformin in diabetes mellitus type 2 patients.
- HF = heart failure.
- βB: beta adrenoceptor blocker.
- RAAS-I: inhibitor of the renin-angiotensin-aldosterone system.
- AldoA: aldosterone antagonist.
- AF = atrial fibrillation.
- OAK: oral anticoagulation.
- CVD = cardiovascular disease.
- PAI: platelet aggregation inhibitor (acetylsalicylic acid or clopidogrel/prasugrel).
- MCI = myocardial infarction.
